MDXH: MDxHealth, Inc. Market Cap to Revenue Ratio

Symbol and logo of brand MDxHealth S.A. (MDXH)

MDxHealth SA ensures the rapid delivery of urological samples to laboratories while maintaining their quality. The estimated P/S ratio in the GURU.Markets terminal reflects the business value-to-revenue dynamics, where the current level is 0.10. Patents and FDA approval create a high barrier to entry for competitors. The company is implementing DNA genetic tests that allow for the avoidance of unnecessary prostate biopsies.

MDXH (mdxhealth.com) P/S Multiple history from 07/04/2022 to 11/13/2026

Analytical breakdowns for MDxHealth Inc. (MDXH)

- market price and analyst price targets:
Stock Quotes mdxhealth.com|MDXH - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization MDxHealth Inc.|MDXH - Real Price to Acquire Entire Company
- business book valuation details:
Equity per Share MDxHealth SA|MDXH - Book Capitalization|Market Value to Book Value mdxhealth.com|MDXH - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital MDxHealth SA|MDXH - Long-Term Debt to Capital|Short-Term Debt to Capital MDxHealth, Inc.|MDXH - Company Debts|Debt to Book Capitalization Ratio MDxHealth Inc.|MDXH - Company Long-Term Liabilities|Amount of Current Liabilities MDxHealth SA|Intermediate Coverage Ratio mdxhealth.com
- net income and valuation multiples indicators:
MDXH - Net Income|Expected Net Income MDxHealth SA|MDXH - Price to Earnings Ratio|Market Cap to Projected Earnings MDxHealth S.A.|MDXH - PEG Multiple|EV/EBITDA Multiple MDxHealth Inc.|MDXH - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months MDxHealth SA|MDXH - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months mdxhealth.com|MDXH - Net earnings per share growth this year|Projected earnings per share growth rate for next year MDxHealth SA
- issuer revenue and sales details:
MDXH - Revenue and Sales Volume|Company Future Revenue mdxhealth.com|MDXH - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple MDxHealth Inc.
Fundamental company analysis:mdxhealth.com MDXH
Mass-produced product of MDxHealth Inc.

The expansion of the MDxHealth diagnostic ecosystem and the broadening of Medicare insurance coverage are directly reflected in the price-to-sales ratio. This indicator compares market capitalization to sales volume, allowing investors to determine the premium paid for every dollar of revenue and identify abnormal deviations of the business value from its actual operational growth dynamics.

Who MDxHealth SA competes with

Market Cap to Revenue agilent.com A|P/S Multiple DGX (Quest Diagnostics Incorporated)|ILMN: Market Cap to Revenue Ratio|EXAS: Market Cap to Revenue|RVTY (Revvity Corp) - Market Cap to Revenue Ratio|BIO: P/S Multiple|anbio.com - Market Capitalization-to-Revenue Ratio|SHC (Sotera Health) - P/S Multiple|Price to Sales Quidel Corporation QDEL|P/S Multiple OPK|P/S Multiple CareDx Health (CDNA)|Price-to-Revenue Ratio Maravai LifeSciences MRVI|fulgentgenetics.com - Price-to-Revenue Ratio|LAB: Market Cap to Revenue|Cytek Biosciences Inc - Market Cap to Sales Volume|OSUR: P/S Multiple|Exagen - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue LUCD|PRE: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Insight Molecular Diagnostics (IMDX)|Price-to-Revenue Coefficient trinitybiotech.com|P/S Multiple PRPH (ProPhase)|P/S Multiple Ainos Corporation AIMD|CODX - Price-to-Revenue Ratio|heartsciences.com (HSCS) - Market Cap to Revenue|BMRA: P/S Multiple|Market Cap to Revenue Ratio CDIO|Market Cap to Revenue ONCO|Market Cap to Revenue Ratio VRAX (Virax Biolabs Corp)|P/S Multiple BJDX|AWH (aspirawh.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|CNTG - Market Cap to Revenue|Enzo - P/S Multiple|Price to Sales Fresh2 Group Limited|GENE: P/S Multiple|Market Cap to Revenue Ratio ME|PMD (Psychemedics Corporation) - P/S Multiple